English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduA new study by Penn researchers examined, for the first time, the differences in lung transplant graft outcomes from organs recovered from the two types of deceased organ donor care facilities operating in the United States.
Tag: Penn Medicine
Penn Medicine Brings Free 3D Mammograms and Health Screenings Back to West Philly
Penn Medicine will once again join with community partners and Siemens Healthineers to host a free mammogram clinic and community health fair in June, giving the West Philadelphia and Upper Darby communities convenient access to health screenings right in their neighborhoods.
Invitation to Cover: Perelman School of Medicine Students Meet Their Match
On Friday, March 15, the Perelman School of Medicine (PSOM) at the University of Pennsylvania will celebrate Match Day, the annual event that reveals where graduating medical students will head for residency programs to further their training.
Penn Medicine Researchers Develop Gene Editing Approaches for Phenylketonuria Treatment
Phenylketonuria (PKU) is a rare newborn genetic disease that impacts between 1 in 10,000 to 1 in 20,000 people, depending on the individuals’ genetic ancestry. PKU causes an amino acid—called phenylalanine (Phe)—to build up in the bloodstream.
Penn Research Projects Increase in U.S. Cardiovascular Deaths Due to Extreme Heat
The number of heat related cardiovascular deaths in the United States will increase over the next four decades, according to a new analysis from the Perelman School of Medicine at the University of Pennsylvania.
Inflammatory Bowel Disease Linked to Atopic Dermatitis, Penn Medicine Research Finds
Adults with atopic dermatitis (AD) have a 34 percent increased risk of developing new-onset inflammatory bowel disease (IBD) compared with individuals who do not have the skin condition, and children have a 44 percent increased risk, according to a new study from the Perelman School of Medicine at the University of Pennsylvania.
Kevin Kline, MD, Appointed as Penn Medicine’s Inaugural Medical Director for LGBTQ+ Health
In his new role, Kline will partner with fellow leaders at Penn Medicine’s Program for LGBTQ+ Health.
Penn Medicine Researchers Awarded $27.5 Million for Large Palliative Care Study
A Penn Medicine research team has been approved for a $27.5 million funding award from the Patient-Centered Outcomes Research Institute (PCORI) for a large study on effectively and equitably scaling and delivering inpatient palliative care.
Antibody Treatment Prevents Graft Versus Host Disease, a Major Bone Marrow Transplant Complication, in Advanced Preclinical Tests
An experimental antibody treatment largely prevented a bone marrow transplant complication called graft versus host disease (GVHD) in the intestines, without causing broad immune suppression, in a preclinical study led by researchers from Penn Medicine and Dana-Farber/Boston Children’s Cancer and Blood Disorders Center and published today in Science Translational Medicine.
Discovering Cell Identity: $6 Million NIH Grant Funds New Penn Medicine Research to Uncover Cardiac Cell Development
Historically, scientists have studied how cells develop and give rise to specialized cells, such as heart, liver, or skin cells, by examining specific proteins.
Real-World Data Suggests Stopping Immunotherapy after Two Years is Reasonable in Patients with Advanced Lung Cancer
A new study from Penn Medicine’s Abramson Cancer Center suggests that it’s reasonable for patients with advanced lung cancer to stop immunotherapy treatment at two years, as long as their cancer hasn’t progressed.
Penn Medicine to Offer Free Cancer Screenings, including 3D Mammograms with Siemens Healthineers, at June Community Events in and around West Philadelphia
As part of a continued focus on making cancer screenings more accessible to the greater Philadelphia community, Penn Medicine is providing free cancer screenings, no insurance required, including advanced 3D mammograms, in West Philadelphia this June.
Two Penn Medicine Abramson Cancer Center Faculty Members Receive Top ASCO Awards
Two esteemed leaders from the Penn Medicine Abramson Cancer Center and Perelman School of Medicine at the University of Pennsylvania will be honored with 2023 Special Awards from the American Society for Clinical Oncology (ASCO), and Conquer Cancer, the ASCO Foundation, during the 2023 ASCO Annual Meeting.
Penn Medicine at the American Society of Gene and Cell Therapy 26th Annual Meeting
Researchers from the Gene Therapy Program (GTP) at the Perelman School of Medicine at the University of Pennsylvania will present nine abstracts highlighting their translational science and discovery research on gene therapy, gene editing, and adeno-associated virus (AAV) vector technology at the American Society of Cell and Gene Therapy (ASGCT) 26th Annual Meeting on May 16–20, 2023 in Los Angeles, California.
AACR: Penn Medicine Preclinical Study Identifies New Target for Recurrent Ovarian Cancer
Results from a preclinical study from Penn Medicine, presented at the AACR Annual Meeting 2023, verified a new target for drug-resistant ovarian cancer and provided data to support a treatment approach that is already making its way into clinical trials.
Four Penn Medicine Abramson Cancer Center Researchers Receive Top AACR Awards
Four distinguished researchers from the Abramson Cancer Center and Perelman School of Medicine at the University of Pennsylvania will receive 2023 Scientific Achievement Awards from the American Association for Cancer Research (AACR), during the AACR Annual Meeting 2023.
Penn Medicine Researchers Develop Model to Predict Cardiovascular Risk Among Chronic Kidney Disease Patients
Chronic kidney disease is a strong cardiovascular risk factor and is often accompanied by hypertension and diabetes. A new risk model for cardiovascular disease, developed by Penn, was found to be more accurate than existing clinical models.
Machine Learning-Triggered Reminders Improve End-of-Life Care for Patients with Cancer
Electronic nudges delivered to health care clinicians based on a machine learning algorithm that predicts mortality risk quadrupled rates of conversations with patients about their end-of-life care preferences, according to the long-term results of a randomized clinical trial published by Penn Medicine investigators in JAMA Oncology today.
Penn Medicine Awarded $9.7 Million from The Warren Alpert Foundation for Genetic Counselor Continuing Education Efforts
Penn Medicine has received a $9.7 million grant from The Warren Alpert Foundation (WAF) that will fund continuing education efforts for genetic counselors, to ensure opportunities for continued training that will keep them on the leading edge of their profession interpreting genomic data and explaining its implications to patients.
Penn Medicine Invests in Future Nurses with ASPIRE Program at the Hospital of the University of Pennsylvania
Penn Medicine has partnered with the Howley Foundation and La Salle University to launch the ASPIRE Program at the Hospital of the University of Pennsylvania (HUP), marking an important investment in the future of nursing.
Penn Medicine Launches New Center for Living Donation to Increase Transplant Opportunities for Those in Need of Livers or Kidneys
The Penn Transplant Institute at Penn Medicine has opened a new Center for Living Donation which will expand Penn’s exceptional care for living donors, helping to maximize the number of lives saved through liver and kidney transplantation. For the thousands waiting on a lifesaving organ, living donation—when a living person donates an organ, or part of an organ, for transplantation to another person—can help those in need receive life-saving care sooner.
Novel Drug Shows Early Promise in Treating Multiple Myeloma
A first-of-its-kind drug known as modakafusp alfa has shown early potential in combating multiple myeloma, a form of bone marrow cancer, in a study presented by researchers from the University of Pennsylvania’s Abramson Cancer Center at the 2022 American Society of Hematology (ASH) Annual Meeting (Abstract 565).
Penn Medicine Researchers Present Advance in Re-Treatment with CAR T Therapy
Researchers from the University of Pennsylvania’s Abramson Cancer Center presented preliminary results of an ongoing Phase I clinical trial demonstrating successful re-treatment with CAR T cell therapy for patients whose cancers relapsed after previous CAR T therapy at the 2022 American Society of Hematology (ASH) Annual Meeting (Abstract 2016).
Penn Medicine at the 2022 ASH Meeting
Researchers from the Abramson Cancer Center and Perelman School of Medicine at the University of Pennsylvania will be presenting data on the latest advances in blood cancer research and treatment at the 2022 American Society of Hematology (ASH) Annual Meeting from December 10-13.
Penn Medicine Receives $3.5 Million NCI Grant to Improve Cervical Cancer Care in Botswana
Penn Medicine experts have worked with local partners to improve health care in Botswana for years. Now, a new $3.5 million grant from the NCI will help further that work by addressing one of Botswana’s most serious health challenges: cervical cancer.
South Jersey’s First Proton Therapy Center Previews New Facility
Two renowned health systems are bringing the most advanced form of radiation treatment to cancer patients in South Jersey, with the creation of the Penn Medicine |Virtua Health Proton Therapy Center in Voorhees, N.J.
Penn Medicine CAREs Grants Fuel Community Support—From STEM Education to Alzheimer’s Disease Caregiver Respite
Thirty initiatives were supported by Penn Medicine CAREs grants this past quarter, along with programs to provide caregiver respite and encourage STEM education.
$50 Million Gift to Accelerate Colton Center for Autoimmunity at Penn Medicine
A $50 million gift from Stewart and Judy Colton will accelerate the existing Colton Center for Autoimmunity at the University of Pennsylvania’s Perelman School of Medicine into an internationally leading center of autoimmune research and treatment with a dedicated space, powerful recruitment capabilities, scientific resources, and more. This gift builds on a $10 million gift from the Coltons, which established the Colton Center for Autoimmunity at Penn in the fall of 2021.
Penn Research Finds Psoriasis Medication Apremilast Leads to Fat Loss in People with Psoriasis
Apremilast (brand name Otezla) has helped psoriasis patients achieve clearer skin and ease the symptoms of their psoriatic arthritis. Now, new data from researchers at the Perelman School of Medicine at the University of Pennsylvania shows it could also help people with psoriasis shed unhealthy body fat and therefore improve cardiovascular health, a well-known vulnerability for those with psoriasis.
Over 10 Years of CAREs—Penn Medicine Continues to Support Staff Giving Back in the Community
Over the last 10 years, the Penn Medicine CAREs grant program has supported staff, faculty, students, and trainees across the organization in helping their communities. This quarter, 36 community programs received funding.
Tribeca Film Festival to Debut Documentary Tracing the Path to Penn Medicine and Children’s Hospital of Philadelphia’s Transformative, Personalized Cancer Therapy
The behind-the-scenes story detailing the pursuit of a transformative cancer cure will unfold onscreen at the Tribeca Film Festival in New York City this weekend. “Of Medicine and Miracles,” which will premiere during the renowned international festival, is an emotional journey, revealing decades of research – and one young patient’s family’s last hopes to save their daughter – that culminated in the world’s first CAR T-cell therapy, an approach that reprograms patients’ own immune cells to kill their cancer.
Grand View Health and Penn Medicine Extend Strategic Alliance Until 2027
In August 2018, Penn Medicine and Grand View Health set a vision to develop collaborative services at Grand View Hospital in an effort to provide comprehensive care that kept patients closer to home. Four years later, the relationship is flourishing, with programs in Cancer (including Radiation Oncology), Trauma, Neurosciences, and Orthopaedics. Early this month, the two organizations signed a renewal of their strategic alliance for five more years.
Penn’s Florencia Greer Polite, MD, Named to 2022 Carol Emmott Fellowship Class
Florencia Greer Polite, MD, chief of the Division of General Obstetrics and Gynecology at the Perelman School of Medicine at the University of Pennsylvania, has been selected for the 2022 Carol Emmott Fellowship class by the Carol Emmott Foundation, a national nonprofit organization dedicated to achieving gender equity in healthcare leadership and governance.
Penn Medicine’s Pavilion Marks a Healthcare ‘First’ with Prestigious LEED Gold Building Certification for Sustainability
Penn Medicine’s new Pavilion on the Hospital of the University of Pennsylvania’s campus has broken new ground for sustainable healthcare construction and design with Leadership in Energy and Environmental Design (LEED) Healthcare Gold Certification.
Creating Green Space and Supporting Student-Athletes – 22 Community Programs Receive Grants Through Penn Medicine CAREs
This quarter, 22 projects will receive Penn Medicine CAREs funding. From leading local park cleanups to providing student-athlete support, employees across Penn Medicine volunteer their time and resources to strengthen the communities they serve, supported by the CAREs program.
Penn Medicine Serving Up Hospitality, Healthy Cafe Options at New Pavilion
Visitors and staff at Penn Medicine’s new Pavilion, opening this October, will have food and drink options that include national celebrity chef Tom Colicchio’s Root & Sprig and Philadelphia coffee guru Thane Wright’s Bower Cafe.
Hospitals with More Inpatient Nurse Practitioners Linked to Better Outcomes, More Satisfied Patients
According to a new study published today in Medical Care, hospitals that employ more inpatient nurse practitioners (NPs) have lower surgical mortality, higher patient satisfaction, and lower costs of care. Nurse practitioners are registered nurses (RNs) with advanced graduate education and expanded legal scope of practice to prescribe treatments including pain medications.
2022 Breakthrough Prize in Life Sciences Awarded to Penn Medicine mRNA Pioneers Drew Weissman and Katalin Karikó
PHILADELPHIA – It was a scientific discovery 16 years ago that paved the way for creation of lifesaving vaccines when the COVID-19 pandemic spread across the globe in 2020. Now, the two Penn Medicine researchers behind the findings are again being recognized for their innovative and monumental work, which has ushered in a new era of vaccine technology.
Penn Presbyterian Medical Center Trauma Division Launches Partnership with United States Navy
Representatives from Penn Medicine and the United States Navy will sign a unique agreement today marking the start of a three-year partnership to integrate members of the Navy with the Trauma Division at Penn Presbyterian Medical Center (PPMC). The program, known as the Naval Strategic Health Alliance for Readiness and Performance, is designed to provide sustained experiences in all aspects of trauma care – from surgery to anesthesiology to nursing – in one of the nation’s busiest trauma centers. The eleven Navy team members bring a wealth of experience with multiple deployments around the globe that will promote new approaches and knowledge across both civilian and military healthcare.
Penn mRNA Researchers Drew Weissman and Katalin Karikó Awarded the 2021 Albany Prize
PHILADELPHIA – For their landmark research that set a foundation for the mRNA SARS-CoV-2 vaccines, Drew Weissman, MD, PhD, the Roberts Family Professor of Vaccine Research, and Katalin Karikó;, PhD, an adjunct professor of Neurosurgery at the Perelman School of Medicine at the University of Pennsylvania and a senior vice president at BioNTech, have been selected to receive the 2021 Albany Prize.
Penn Medicine Discovery Clarifies the Problem of T-Cell “Exhaustion”
Researchers have discovered a limitation of the immune system in battles against cancers or viruses: T cells remain programmed to stay exhausted even weeks after exposure to a virus ended. Scientists need to take this “T cell exhaustion” into account when devising immune-based therapies.
New Approach for Cell Therapy Shows Potential Against Solid Tumors with KRAS Mutations
A new technology for cellular immunotherapy developed by Abramson Cancer Center researchers at Penn Medicine showed promising anti-tumor activity in the lab against hard-to-treat cancers driven by the once-considered “undruggable” KRAS mutation, including lung, colorectal, and pancreatic.
Basser Center for BRCA Awards 2021 Basser Global Prize to National Cancer Institute’s Andre Nussenzweig
The Basser Center for BRCA at the Abramson Cancer Center of the University of Pennsylvania, the world’s first comprehensive center aimed at advancing research, treatment, and prevention of BRCA-related cancers, has announced Andre Nussenzweig, PhD, of the National Cancer Institute (NCI) as the recipient of the ninth annual Basser Global Prize. Nussenzweig serves as branch chief of the Laboratory of Genome Integrity in the NCI’s Center for Cancer Research.
Pulling Wisdom Teeth Can Improve Long-Term Taste Function
Patients who had their wisdom teeth extracted had improved tasting abilities decades after having the surgery.
Penn Medicine to Use $1M from City of Philadelphia for Additional Community Vaccination Clinics
Penn Medicine will continue its collaboration with the West and Southwest Philadelphia communities to operate a series of COVID-19 vaccine clinics in partnership with community organizations, faith-based institutions, restaurants, barbershops, and even professional sports teams thanks to $1 million in funding from the City of Philadelphia, in partnership with PMHCC.
Penn Medicine Hospitals Ranked #50 Globally on Newsweek’s “World’s Best Smart Hospitals 2021” List
The Hospital of the University of Pennsylvania (HUP) and Penn Presbyterian Medical Center (PPMC) rank #27 in the United States and #50 globally on Newsweek’s World’s Best Smart Hospitals 2021, which ranks the 250 best medical institutions that are leading the field in smart technologies, like digital surgery, imaging, artificial intelligence, telehealth and electronic medical records. Results are based on worldwide recommendations from medical professionals.
Black and White Women Have Same Mutations Linked to Breast Cancer Risk
The prevalence of genetic mutations associated with breast cancer in Black and white women is the same.
Penn Medicine at the 2021 ASCO Meeting
Researchers from the Abramson Cancer Center at the University of Pennsylvania will be presenting data on the latest advances in cancer research and treatment at American Society of Clinical Oncology virtual annual meeting, including new findings on minority health, immunotherapy, and…
Low on Antibodies, Blood Cancer Patients Can Fight off COVID-19 with T Cells
Antibodies aren’t the only immune cells needed to fight off COVID-19 — T cells are equally important and can step up to do the job when antibodies are depleted, suggests a new Penn Medicine study of blood cancer patients with COVID-19 published in Nature Medicine.
Penn Nursing-led Philly Team Awarded $1.4 Million NIH Grant to Expand COVID-19 Outreach
José A. Bauermeister, PhD, and Antonia M. Villarruel, PhD, are leading one of 10 new research teams from across the country that received National Institutes of Health (NIH) grants totaling $14 million to extend the reach of the NIH’s Community Engagement Alliance (CEAL) Against COVID-19 Disparities. The Philly CEAL team was awarded $1.4 million from the NIH with additional support from Penn Nursing and The University of Pennsylvania, bringing the total for the alliance to $1.53 million.